These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34423789)

  • 21. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
    Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function.
    Tomas C; Elson JL; Strassheim V; Newton JL; Walker M
    PLoS One; 2020; 15(4):e0231136. PubMed ID: 32275686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.
    Mueller C; Lin JC; Sheriff S; Maudsley AA; Younger JW
    Brain Imaging Behav; 2020 Apr; 14(2):562-572. PubMed ID: 30617782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH; Maya J; Giloteaux L; Peterson DL; Maynard M; Gottschalk CG; Hanson MR
    J Clin Invest; 2020 Mar; 130(3):1491-1505. PubMed ID: 31830003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
    Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
    PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
    Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
    J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
    Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
    Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Yamano E; Watanabe Y; Kataoka Y
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.